Adenoviral/retroviral vector chimeras: A novel strategy to achieve high- efficiency stable transduction in vivo

FASEB Journal

Volumn 11, Issue 8, 1997, Pages 624-634

  Bilbao, Guadalupe ^a   Feng, Meizhen ^a   Rancourt, Claudine ^a   Jackson Jr , William H ^a   Curiel, David T ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Adenoviral vector; Retrovirus; Transgene sequence; Vector chimera gene delivery

Indexed keywords

ADENOVIRUS; CHIMERA; EXPRESSION VECTOR; GENE TARGETING; GENE TECHNOLOGY; GENE THERAPY; GENE TRANSFER; GENETIC DISORDER; HUMAN; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; REVIEW; SIGNAL TRANSDUCTION;

ADENOVIRIDAE; UNIDENTIFIED RETROVIRUS;

EID: 0030806875     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.11.8.9240964     Document Type: Review

References (111)

1. Anderson, W. F. (1984) Prospects for human gene therapy. Science 226, 401-409
2. Miller, A. D. (1990) Progress toward human gene therapy. Blood 76, 271-278
3. Feigner, P. L., and Rhodes, G. (1991) Gene therapeutics. Nature (London) 349, 351-352
4. Hanania, E. G., Kavanagh, J., Hortobagyi, G., Giles, R. E., Champlin, R., and Deisseroth, A. B. (1995) Recent advances in the application of gene therapy to human disease. Am. J. Med. 99, 537-552
5. Roemer, K., and Friedmann, T. (1992) Concepts and strategies for human gene therapy. Ear. J. Biochem. 208, 211-225
6. Klein, H. G. (1994) Cellular gene therapy. An overview. J. Clin. Apheresis 9, 139-141
7. Nabel, E. G., and Nabel, G. J. (1993) Direct gene transfer: basic studies and human therapies. Thromb. Haemostasia 70, 202-203
8. Wilson, J. M. (1995) Gene therapy for cystic fibrosis: Challenges and future directions. J. Clin. Invest. 96, 2547-2554
9. Rosenfeld, M. A., and Collins, F. S. (1996) Gene therapy for cystic fibrosis. Chest 109, 241-252
10. Korst, R. J., McElvaney, N. G., Chu, C.-S., Rosenfeld, M. A., Mastrangeli, A., Hay, J., Brody, S. L., Eissa, N. T., Danel, C., Jaffe, H. A., and Crystal, R. G. (1995) Gene therapy for the respiratory manifestations of cystic fibrosis. Am. J. Resp. Crit. Care Med. 51, S75-S87
11. Coutelle, C., Caplen, N.J., Hart, S. L., Middleton, P. G., and Williamson, R. (1994) Towards gene therapy for cystic fibrosis. In Cystic Fibrosis - Current Topics (Dodge, J. A., Brock, D. J. H., Widdicombe, J. H., eds) pp. 33-54
12. Coutelle, C. (1995) Gene therapy approaches for cystic fibrosis. Biologicals 23, 21-25
13. Wagner, J. A., Chao, A. C., and Gardner, P. (1995) Molecular strategies for therapy of cystic fibrosis. Ann. Rev. Pharmacol. Toxicol. 35, 257-276
14. Goldman, M. J., Yang, Y., and Wilson, J. M. (1995) Gene therapy in a xenograft model of cystic fibrosis lung corrects chloride transport more effectively than the sodium defect. Nature Genet. 9, 126-131
15. Engelhardt, J. F., Yang, Y., Stratford-Perricaudet, L. D., Allen, E. D., Kozarsky, K., Perricaudet, M., Yankaskas, J. R., and Wilson, J. M. (1993) Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1-deleted adenoviruses. Nature Genet. 4, 27-33
16. Zsengeller, Z. K., Wert, S. E., Hull, W. M., Hu, X., Yei, S., Trapnell, B. C., and Whitsett, J. A. (1995) Persistence of replication-deficient adenovirus-mediated gene transfer in lungs of immune-deficient (nu/nu) mice. Human Gene Ther. 6, 457-467
17. Zabner, J., Couture, L. A., Smith, A. E., and Welsh, M. J. (1994) Correction of cAMP-stimulated fluid secretion in cystic fibrosis airway epithelia: Efficiency of adenovirus-mediated gene transfer in vitro. Human Gene Ther. 5, 585-593
18. Johnson, L. G., Olsen, J. C., Sarkadi, B., Moore, K. L., Swanstrom, R., and Boucher, R. C. (1992) Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis. Nature Genet. 2, 21-25
19. Knowles, M. R., Hohneker, K. W., Zhou, Z., Olsen, J. C., Noah, T. L., et al. (1995) A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. N. Engl. J. Med. 333, 823-831
20. Fox, J. C. (1996) Cardiovascular gene therapy: Current concepts. Ther. Drug Monitoring 18, 410-122
21. Nuss, H. B., Johns, D. C., Kaab, Tomaselli, G. F., Kass, D., Lawrence, J. H., and Marban, E. (1996) Reversal of potassium channel deficiency in cells from failing hearts by adenoviral gene transfer: a prototype for gene therapy for disorders of cardiac excitability and contractility. Gene Therapy 3, 900-912
22. Schulick, A. H., Vassalli, G., Dunn, P. F., Dong, G., Rade, J. J., Zamarron, C., and Dichek, D. A. (1997) Established immunity precludes adenovirus-mediated gene transfer in rat carotid arteries. J. Clin. Invest. 99, 209-219
23. Lozier, J. N., and Brinkjous, K. M. (1994) Gene therapy and the hemophilias. J. Am. Med. Assoc. 271, 47-51
24. Kurachi, K., and Yao, S.-N. (1993) Gene therapy of hemophilia B. Thromb. Haemostasis 70, 193-197
25. Yao, S.-N., Wilson, J. M., Nabel, E. G., Kurachi, S., Hachiya, H. L., and Kurachi, K. (1991) Expression of human factor IX in rat capillary endothelial cells: Toward somatic gene therapy for hemophilia B. Proc. Natl. Acad. Sci. USA 88, 8101-8105
26. Dai, Y., Roman, M., Naviaux, R. K., and Verma, I. M. Gene (1992) Therapy via primary myoblasts: Long-term expression of factor IX protein following transplantation in vivo. Proc. Natl. Acad. Sci. USA 89, 10892-10895
27. Kay, M. A,. Rothenberg, S., Landen, C. N., Bellinger, D. A., Leland, F., Toman, C., Finegold, M., Thompson, A. R., Read, M. S., Brinkjous K. M., and Woo, S. L. C. (1993) In vivo gene therapy of hemophilia B: Sustained partial correction in factor IX-deficient dogs. Science 262, 117-119
28. Cardoso, J. E., Branchereau, S., Jeyaraj, P. R., Houssin, D., Danos, O., and Heard, J. M. (1993) In situ retrovirus-mediated gene transfer into dog liver. Human Gene Ther. 4, 411-418
29. Kaleko, M., Garcia, J. V., and Miller, A. D. (1991) Persistent gene expression after retroviral gene transfer into liver cells in vivo. Human Gene Ther. 2, 27-32
30. Kay, M. A., Li, Q., Liu, T.-J., Leland, F., Toman, C., Finegold, M., and Woo, S. L. C. (1992) Hepatic gene therapy: Persistent expression of human 1-antitrypsin in mice after direct gene delivery in vivo. Human Gene Ther. 3, 641-647
31. Jaffe, H. A., Danel, C., Longenecker, G., Matzger, M., Setoguchi, Y., Rosenfeld, M. A., Gant, T. W., Thorgeirsson, S. S., Stratford-Perricaudet, L. D., Perricaudet, M., Pavirani, A., Lecocq, J.-P., and Crystal, R. G. (1992) Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nature Genet. 1, 372-378
32. Smith, T. A. G., Mehaffey, M. G., Kayda, D. B., Saunders, J. M., Yei, S., Trapnell, B. C., McClelland, A., and Kaleko, M. (1993) Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nature Genet. 5, 397-402
33. Morsy, M. A., Alford, E. L., Bett, A., Graham, F. L., and Caskey, C. T. (1993) Efficient adenoviral-mediated ornithine transcarbamylase expression in deficient mouse and human hepatocytes. J. Clin. Invest. 92, 1580-1586
34. Herz, J., and Gerard, R. D. (1993) Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc. Natl. Acad. Sci. USA 90, 2812-2816
35. Kozarsky, K., Grossman, M., and Wilson, J. M. (1993) Adenovirus-mediated correction of the genetic defect in hepatocytes from patients with familial hypercholesterolemia. Somatic Cell Mol. Genet. 19, 449-458
36. Ishibashi, S., Brown, M. S., Goldstein, J. L., Gerard, R. D., Hammer, R. E., and Herz, J. (1993) Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. Clin. Invest. 92, 883-893
37. Strauss, M. (1994) Liver-directed gene therapy: Prospects and problems. Gene Therapy 1, 156-164
38. Kozarsky, K. F., McKinley, D. R., Austin, L. L., Raper, S. E., Stratford-Perricaudet, L. D., and Wilson, J. M. (1994) In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses. J. Biol. Chem. 269, 13695-13702
39. Kay, M. A., Graham, F., Leland, F., and Woo, S. L. C. (1995) Therapeutic serum concentrations of human alpha-1-antitrypsin after adenoviral-mediated gene transfer into mouse hepatocytes. Hepatology 21, 815-819
40. Kozarsky, K. F., Jooss, K., Donahee, M., Strauss, J. F., III, and Wilson, J. M. (1996) Effective treatment of familial hypercholesterolaemia in the mouse model using adenovirus-mediated transfer of the VLDL receptor gene. Nature Genet. 13, 54-62
41. Ye, X., Robinson, M. B., Batshaw, M. L., Furth, E. E., Smith, I., and Wilson, J. M. (1996) Prolonged metabolic correction in adult ornithine transcarbamylase-deficient mice with adenoviral vectors. J. Biol. Chem. 271, 3639-3646
42. Grubb, B. R., Pickles, R. J., Ye, H., Yankaskas, J. R., Vick, R. N., Engelhardt, J. F., Wilson, J. M., Johnson, L. G., and Boucher, R. C. (1994) Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans. Nature (London) 371, 802-806
43. Dupuit, F., Zahm, J.-M., Pierrot, D., Brezillon, S., Bonnet, N., Imler, L.-L., Pavirani, A., and Puchelle, E. (1995) Regenerating cells in human airway surface epithelium represent preferential targets for recombinant adenovirus. Human Gene Ther. 6, 1185-1193
44. Pickles, R. J., Barker, P. M., Ye, H., and Boucher, R. C. (1996) Efficient adenovirus-mediated gene transfer to basal but not columnar cells of cartilaginous airway epithelia. Human Gene Ther. 7, 921-931
45. Zabner, J., Zeiher, B. G., Friedman, E., and Welsh, M. J. (1996) Adenovirus-mediated gene transfer to ciliated airway epithelia requires prolonged incubation time. J. Virol. 70, 6994-7003
46. Goldman, J. J., and Wilson, J. M. (1995) Expression of a v5 integrin is necessary for efficient adenovirus-mediated gene transfer in the human airway. J. Virol. 69, 5951-5958
47. Goldman, M., Su, Q., and Wilson, J. M. (1996) Gradient of RGD-dependent entry of adenoviral vector in nasal and intrapulmonary epithelia: Implications for gene therapy of cystic fibrosis. Gene Ther. 3, 811-818
48. Wickham, T. J., Segal, D. M., Roelvink, P. W., Carrion, M. E., Lizonova, A., Lee, G. M., and Kovesdi, I. (1996) Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies. J. Virol. 70, 6831-6838
49. Michael S. I., and Curiel, D. T. (1995) Strategies to achieve targeted gene delivery via the receptor-mediated endocytosis pathway. Gene Ther. 1, 223-232
50. Douglas, J. T., and Curiel, D. T. (1995) Targeted gene therapy. Tumor Targeting 1, 67-84
51. Krasnykh, V. N., Mikheeva, G. V., Douglas, J. T., and Curiel, D. T. (1996) Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism. J. Virol. 70, 6839-6846
52. Douglas, J. T., Rogers, B. E., Rosenfeld, M. E., Michael, S. I., Feng, M., and Curiel, D. T. (1996) Targeted gene delivery by tropism-modified adenoviral vectors. Nature Biotechnol. 14, 1574-1578
53. Miller, N., and Vile, R. (1995) Targeted vectors for gene therapy. FASEB J. 9, 190-199
54. Yang, Y., Nunes, F. A., Berencsi, K., Furth, E. E., Gonczol, E., and Wilson, J. M. (1994) Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91, 4407-4411
55. + CTLs in vivo. J. Immunol. 155, 2564-2570
56. Yang, Y., Ertl, H. C., and Wilson, J. M. (1995) MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1, 433-442
57. Yang, Y., Li, Q., Ertl, H. C., and Wilson, J. M. (1995) Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69, 2004-2015
58. Yang, Y., Xiang, Z., Ertl, H. C., and Wilson, J. M. (1995) Upregulation of class I major histocompatibility complex antigens by Interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo. Proc. Natl. Acad. Sci. USA 92, 7257-7261
59. Engelhardt, J. F., Ye, X., Doranz, B., and Wilson, J. M. (1994) Ablation of E2A in rebcombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc. Natl. Acad. Sci. USA 91, 6196-6200
60. Fisher, K. J., Choi, H., Burda, J., Chen, S. J., and Wilson, J. M. (1996) Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis. Virology 217, 11-22
61. Gorziglia, M. I., Kadan, M. J., Yei, S., Lim, J., Lee, G. M., Luthra, R., and Trapnell, B. C. (1996) Elimination of both E1 and E2 from adenovirus vectors further improves prospects for in vivo human gene therapy. J. Virol. 70, 4173-4178
62. Mittal, S. K., McDermott, M. R., Johnson, D. C., Prevec, L., and Graham, F. L. (1993) Monitoring foreign gene expression by a human adenovirus-based vector using the firefly luciferase gene as a reporter. Virus Res. 28, 67-90
63. Lemarchand, P., Ari Jaffe, H., Danel, C., Cid, M. C., Kleinman, H. K., Stratford-Perricaudet, L. D., Perricaudet, M., Pavirani, A., Lecocq, J.-P., and Crystal, R. G. (1992) Adenovirus-mediated transfer of a recombinant human 1-antitrypsin cDNA to human endothelial cells. Proc. Natl. Acad. Sci. USA 89, 6482-6486
64. Hitt, M., Bett, A. J., Addison, G. L., Prevec, L., and Graham, F. L. (1995) Techniques for human adenovirus vector construction and characterization. Methods Mol. Genet. 7, 13-30
65. Imler, J.-L. (1995) Adenovirus vectors as recombinant viral vaccines. Vaccine 13, 1143-1151
66. Vile, R. G., and Russell, S. J. (1995) Retroviruses as vectors. Br. Med. Bull. 51, 12-30
67. Miller, A. D. (1992) Retroviral vectors. Curr. Top. Microbiol. Immunol. 158, 1-24
68. Flotte, T. R., Afione, S. A., Conrad, C., McGrath, S. A., Solow, R., Oka, H., Zeitlin, P. L., Guggino, W. B., and Carter, B. J. (1993) Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc. Natl. Acad. Sci. USA 90, 10613-10617
69. Zeitlin, P. L., Chu, S., Conrad, C., McVeigh, U., Ferguson, K., Flotte, T. R., and Guggino, W. B. (1995) Alveolar stem cell transduction by an adeno-associated viral vector. Gene Ther. 2, 623-631
70. Hatzoglou, M., Lamers, W., Bosch, F., Wynshaw-Boris, A., Clapp, D. W., and Hanson, R. W. (1990) Hepatic gene transfer in animals using retroviruses containing the promoter from the gene for phosphoenolpyruvate carboxykinase. J. Biol. Chem. 265, 17285-17293
71. Ferry, N., Duplessis, O., Houssin, D., Danos, O., and Heard, J.-M. (1991) Retroviral-mediated gene transfer into hepatocytes in vivo. Proc. Natl. Acad. Sci. USA 88, 8377-8381
72. Kolodka, T. M., Finegold, M., and Woo, S. L. C. (1993) Hepatic gene therapy: Efficient retroviral-mediated gene transfer into rat hepatocytes in vivo. Somatic Cell Mol. Genet. 19, 491-497
73. Dunckley, M. G., Wells, D. J., Walsh, F. S., and Dickson, G. (1993) Direct retroviral-mediated transfer of a dystrophin minigene into mdx mouse muscle in vivo. Human Mol. Genet. 2, 717-723
74. Moscioni, A. D., Rozga, J., Neuzil, D.F., Overell, R. W., Holt, J. T., and Demetriou, A. A. (1993) In vivo regional delivery of retrovirally mediated foreign genes to rat liver cells: Need for partial hepatectomy for successful foreign gene expression. Surgery 113, 304-311
75. Kolodka, T. M., Finegold, M., and Woo, S. L. C. (1993) Hepatic gene therapy: Efficient retroviral-mediated gene transfer into rat hepatocytes in vivo. Somatic Cell Mol. Genet. 19, 491-497
76. Ram, Z., Walbridge, S., Oshiro, E. M., Viola, J. J., Chiang, Y., Mueller, S. N., Blaese, R. M., and Oldfield, E. H. (1994) Intrathecal gene therapy for malignant leptomeningeal neoplasia. Cancer Res. 54, 2141-2145
77. Rettinger, S. D., Kennedy, S. C., Wu, X., Saylors, R. L., Hafenrichter, D. G., Flye, M. W., and Ponder, K. P. (1994) Liver-directed gene therapy: Quantitative evaluation of promoter elements by using in vivo retroviral transduction. Proc. Natl. Acad. Sci. USA 91, 1460-1464
78. Sajjadi, N., Kamantigue, E., Edwards, W., Howard, T., Jolly, D., Mento, S., and Chada, S. (1994) Recombinant retroviral vector delivered intramuscularly localizes to the site of injection in mice. Human Gene Ther. 5, 693-699
79. Fassati, A., Wells, D. J., Walsh, F. S., and Dickson, G. (1995) Efficiency of in vivo gene transfer using murine retroviral vectors is strain-dependent in mice. Human Gene Ther. 6, 1177-1183
80. Kolodka, T. M., Finegold, M., Moss, L., and Woo, S. L. C. (1995) Gene therapy for diabetes mellitus in rats by hepatic expression of insulin. Proc. Natl. Acad. Sci. USA 92, 3293-3297
81. Bowles, N. E., Eisensmith, R. C., Mohuiddin, R., Pyron, M., and Woo, S. L. C. (1996) A simple and efficient method for the concentration and purification of recombinant retrovirus for increased hepatocyte transduction in vivo. Human Gene Ther. 7, 1735-1742
82. Pensiero, M. N., Wysocki, C. A., Nader, K., and Kikuchi, G. E. (1996) Development of amphotropic murine retrovirus vectors resistant to inactivation by human serum. Human Gene Ther. 7, 1095-1101
83. Sherwin, S. A., Benveniste, R. E., and Todaro, G. J. (1978) Complement-mediated lysis of type-C virus: Effect of primate and human sera on various retroviruses. Int. J. Cancer 21, 6-11
84. Welsh, R. M., Jr., Cooper, N. R., Jensen, F. C., and Oldstone, M. B. A. (1975) Human serum lyses RNA tumour viruses. Nature (London) 257, 612-614
85. Takeuchi, Y., Cosset, F.-L.C., Lachmann, P. J., Okada, H., Weiss, R. A., Collins, and M. K. L. (1994) Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell. J. Virol. 68, 8001-8007
86. Rother, R. P., Squinto, S. P., Mason, J. M., and Rollins, S. A. (1995) Protection of retroviral vector particles in human blood through complement inhibition. Human Gene Ther. 6, 429-435
87. Rother, R. P., Fodor, W. L., Springhorn, J. P., Birks, C. W., Setter. E., Sandrin, M. S., Squinto, S. P., and Rollins, S. A. (1995) A novel mechanism of retrovirus inactivation in human serum mediated by anti-galactosyl natural antibody. J. Exp. Med. 182, 1345-1355
88. Russell, D. W., Berger, M. S., and Miller, A. D. (1995) The effects of human serum and cerebrospinal fluid on retroviral vectors and packaging cell lines. Human Gene Ther. 6, 635-641
89. Short, M. P., Choi, B. C., Lee, J. K., Malick, A., Breakefield, X. O., and Martuza, R. L. (1990) Gene delivery to glioma cells in rat brain by grafting of a retrovirus packaging cell line. J. Neurosci. Res. 27, 427-433
90. Culver, K. W., Ram, Z., Wallbridge, S., Ishii, H., Oldfield, E. H., and Blaese, R. M. (1992) In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256, 1550-1552
91. Takamiya, Y., Short, M. P., Moolten, F. L., Fleet, C., Mineta, T., Breakefield, X. O., and Martuza, R. L. (1993) An experimental model of retrovirus gene therapy for malignant brain tumors. J. Neurosurg. 79, 104-110
92. Ram, Z., Culver, K. W., Walbridge, S., Blaese, R. M., and Oldfield, E. H. (1993) In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res. 53, 83-88
93. Ram, Z., Culver, K. W., Walbridge, S., Frank, J. A., Blaese, R. M., and Oldfield, E. H. (1993) Toxicity studies of retroviral-mediated gene transfer for the treatment of brain tumors. J. Neurosurg. 79, 400-407
94. Caruso, M., Panis, Y., Gagandeep, S., Houssin, D., Salzmann, J.-L., and Klatzmann, D. (1993) Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proc. Natl. Acad. Sci. USA 90, 7024-7028
95. Moorman, D. W., Butler, D. A., Stanley, J. D., Lamsam, J. L., Ackermann, M. R., Jacobson, C. D., and Culver, K. W. (1994) Survival and toxicity of xenogeneic murine retroviral vector producer cells in liver. J. Surg. Oncol. 57, 152-156
96. Baru, M., Sha'anani, J., and Nur, I. (1995) Retroviral-mediated in vivo gene transfer into muscle cells and synthesis of human factor IX in mice. Intervirology 38, 356-360
97. Fassati, A., Wells, D. J., Walsh, F. S., and Dickson, G. (1996) Transplantation of retroviral producer cells for in vivo gene transfer into mouse skeletal muscle. Human Gene Ther. 7, 595-602
98. Hurford, R. K., Jr., Dranoff, G., Mulligan, R. C., and Tepper, R. I. (1995) Gene therapy of metastatic cancer by in vivo retroviral gene targeting. Nature Genet. 10, 430-435
99. Rollins, S. A., Birks, C. W., Setter, E., Squinto, S. P., and, Rother, R. P. (1996) Retroviral vector producer cell killing in human serum is mediated by natural antibody and complement: Strategies for evading the humoral immune response. Human Gene Ther. 7, 619-626
100. Pear, W. S., Nolan, G. P., Scott, M. L., and Baltimore, D. (1993) Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90, 8392-8396
101. Flamant, F., Demeneix, B., Benoist, G., Markossian-Belin, S., and Samarut, J. (1994) Virofection: A new procedure to achieve stable expression of genes transferred into early embryos. Int J. Dev. Biol, 38, 751-757
102. Morling, F. J., and Russell, S. J. (1995) Enhanced transduction efficiency of retroviral vectors coprecipitated with calcium phosphate. Gene Therapy 2, 504-508
103. Flamant, F., and Samarut, J. (1995) Virofection: A one-step procedure for using replication-defective retrovirus vectors. Virology 211, 234-240
104. Finer, M. H., Dull, T. J., Qin, L., Farson, D., and Roberts, M. R. (1994) kat: A high efficiency retroviral transduction system for primary human T lymphocytes. Blood 83, 43-50
105. von Rüden, T., Stingl, L., Cotten, M., Wagner, C., and Zatloukal, K. (1995) Generation of high-titer retroviral vectors following receptor-mediated, adenovirus-augmented transfection. BioTechniques 18, 484-488
106. Noguiez-Hellin, P., Robert-Le Meur, M., Salzmann, J.-L., and Klatzmann, D. (1996) Plasmoviruses: Nonviral/viral vectors for gene therapy. Proc. Natl. Acad. Sci. USA 93, 4175-4180
107. Miller, D. G., Adam, M. A., and Miller, A. D. (1990) Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell. Biol. 10, 4239-4242
108. Lieber, A., Peeters, M. J., Gown, A., Perkins, J., and Kay, M. A. (1995) A modified urokinase plasminogen activator induces liver regeneration without bleeding. Human Gene Ther. 6, 1029-1037
109. Bosch, A., McCray, P. B., Jr., Chang, S. M., Ulich, T. R., Simonet, W. S., Jolly, D. J., and Davidson, B. L. (1966) Proliferation induced by keratinosyte growth factor enhances in vivo retroviral-mediated gene transfer to mouse hepatocytes. J. Clin. Invest. 98, 2683-2687
110. Curiel, D. T. (1994) High-efficiency gene transfer employing adenovirus-polysine-DNA complexes. Nat. Immunity 13, 141-164
111. Fisher, K. J., Kelley, W. M., Burda, J. F., and Wilson, J. M. (1996) A novel adenovirus-adeno-associated virus hybrid vector that displays efficient rescue and delivers of the AAV genome. Human Gene Ther. 7, 2079-2087